A
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
Price:
711.5
INR
-5.11%
Market Cap:
₹64.5B
Relative Value
The Relative Value of one AARTIPHARM stock under the Base Case scenario is hidden INR. Compared to the current market price of 711.5 INR, Aarti Pharmalabs Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AARTIPHARM Relative Value
HIDDEN
Multiples Across Competitors
AARTIPHARM Competitors Multiples
Aarti Pharmalabs Ltd Competitors
Aarti Pharmalabs Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
A
|
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
|
64.5B INR | 3.4 | 26.9 | 15.8 | 20.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
960.1B USD | 14.7 | 46.5 | 31.4 | 33.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579.4B USD | 6.2 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.2B CHF | 4.6 | 30.3 | 12.8 | 14.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228.3B GBP | 5.5 | 33.9 | 16.1 | 23.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.6B CHF | 5.4 | 21.7 | 13.4 | 17.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10.1 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
158B USD | 2.5 | 20.3 | 7.5 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.2B USD | 2.5 | 17.3 | 6.8 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
